Recently, it has been demonstrated that cancer‐derived exosomes transfer functional PD‐L1 and inhibit immune responses,183 while suppression of exosomal PD‐L1 induces systemic anti‐tumour immunity and memory in urological carcinomas,184 and clinical trials have already been initiated to explore their safety and efficacy in humans. The gene discussed is CD274; the disease is cancer.